Metabolomics of Liver Regeneration Following Partial Hepatectomy in Healthy Living Liver Donors

The PI will study metabolism during liver regeneration in living liver donors

Lead sponsor: Baylor Research Institute•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 1

Phase 1 Study of Multiple-Dose Pharmacokinetics of Cenicriviroc in Subjects With Mild and Moderate Hepatic Impairment

NCT02120547 · Liver Insufficiency

UNKNOWNNA

Quantification of Drugs and Their Degradation Products

NCT01828372 · Liver Insufficiency, Kidney Failure, Chronic, and more

UNKNOWNPhase 1

Hepatocyte Matrix Implant Study Indonesia

NCT01335568 · Liver Cirrhosis, Liver Insufficiency, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 28, 2017Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment20

Start dateAug 2013

Last updatedMar 28, 2017

Condition

Liver Insufficiency

Locations shown

Baylor University Medical Center

Dallas, Texas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 28, 2017Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions